Carob extract supplement tested as potential prediabetes aid
NCT ID NCT07420998
First seen Feb 28, 2026 · Last updated Jun 20, 2026 · Updated 12 times
Summary
This study tests whether a liquid supplement made from carob extract can improve blood sugar control in people with prediabetes. Thirty adults with prediabetes will take either the carob supplement or a placebo before meals for a period of time. Researchers will measure changes in blood sugar and insulin levels to see if the supplement helps manage carbohydrate metabolism.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PREDIABETES are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
UCAM HiTech, Sport & Health Innovation Hub
RECRUITINGMurcia, Spain
Contact Phone: •••-•••-•••• Email: •••••@•••••
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
carob extract (NUTIFOOD)
What this could lead to
If it works, this could point toward a simple dietary supplement to help manage prediabetes and reduce the risk of developing type 2 diabetes.
What could go wrong
This is a very small, early-stage trial with only 30 people. The supplement may show no benefit over placebo, and results may not apply to everyone with prediabetes.
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.